Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Graham

Showing results (1131-1140 of 1,460) with videos related to

Pageof 146
Sort By:
Vaccine|March 30, 2007
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccineAndrew T Catanzaro, Mario Roederer, Richard A Koup, et al.
Plos One|May 19, 2010
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infectionEric S Rosenberg, Barney S Graham, Ellen S Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2011
HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectableStephen C De Rosa, Evan P Thomas, John Bui, et al.
Frontiers in Immunology|June 30, 2020
Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen DevelopmentRebecca J Loomis, Guillaume B E Stewart-Jones, Yaroslav Tsybovsky, et al.
The Journal of Infectious Diseases|August 6, 2004
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160Deborah Lee, Barney S Graham, Ya-Lin Chiu, et al.
The Journal of Infectious Diseases|May 13, 2025
Safety, immunogenicity, and protective efficacy in rhesus macaques of a novel recombinant hemagglutinin protein measles virus vaccineJessica H Rubens, Jacqueline K Brockhurst, Shristi Ghimire, et al.
Nature Communications|March 20, 2021
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodiesAdrian Creanga, Rebecca A Gillespie, Brian E Fisher, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variantsKai Wu, Anne P Werner, Juan I Moliva, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2005
Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levelsKoichi Hashimoto, Joan E Durbin, Weisong Zhou, et al.
Science (New York, N.Y.)|April 27, 2013
Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibodyJason S McLellan, Man Chen, Sherman Leung, et al.
Pageof 146

Showing results (1131-1140 of 1,460) with videos related to

Sort By:
Pageof 146
Vaccine|March 30, 2007
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccineAndrew T Catanzaro, Mario Roederer, Richard A Koup, et al.
Plos One|May 19, 2010
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infectionEric S Rosenberg, Barney S Graham, Ellen S Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2011
HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectableStephen C De Rosa, Evan P Thomas, John Bui, et al.
Frontiers in Immunology|June 30, 2020
Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen DevelopmentRebecca J Loomis, Guillaume B E Stewart-Jones, Yaroslav Tsybovsky, et al.
The Journal of Infectious Diseases|August 6, 2004
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160Deborah Lee, Barney S Graham, Ya-Lin Chiu, et al.
The Journal of Infectious Diseases|May 13, 2025
Safety, immunogenicity, and protective efficacy in rhesus macaques of a novel recombinant hemagglutinin protein measles virus vaccineJessica H Rubens, Jacqueline K Brockhurst, Shristi Ghimire, et al.
Nature Communications|March 20, 2021
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodiesAdrian Creanga, Rebecca A Gillespie, Brian E Fisher, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variantsKai Wu, Anne P Werner, Juan I Moliva, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2005
Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levelsKoichi Hashimoto, Joan E Durbin, Weisong Zhou, et al.
Science (New York, N.Y.)|April 27, 2013
Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibodyJason S McLellan, Man Chen, Sherman Leung, et al.
Pageof 146